Source: International Congress 2014 – Biomarkers of asthma and clinical immunology
Disease area: Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Karakina, I. Tuzankina, Y. Beltukov, H. Vlasova (Yekaterinburg, Russian Federation). Non- cystic fibrosis bronchiectasis in primary antibody deficiency patients. Eur Respir J 2014; 44: Suppl. 58, 1044

Member's Comments

No comment yet.

Related content which might interest you: Are non-cystic fibrosis bronchiectasis a result of primary antibody deficiency? Source: International Congress 2015 – Asthma and lung immunology Year: 2015 Case presentation: Should we always treat IgG4-related lung disease? Source: International Congress 2014 – Biomarkers of asthma and clinical immunology Year: 2014 A new risk factor predicts ABPA in patients with cystic fibrosis Source: International Congress 2015 – Cystic fibrosis: assessment and treatment Year: 2015 Cathelicidin has a protective role against pulmonary emphysema Source: International Congress 2014 – Mechanisms of COPD and inhalation injury Year: 2014 Liposomal local therapy of upper respiratory tract involvement in ANCA associated vasculitis Source: International Congress 2014 – Biomarkers of asthma and clinical immunology Year: 2014 Anaerobic and aerobic bacterial load of childhood non- cystic fibrosis bronchiectasis Source: International Congress 2014 – Prevention, diagnosis and consequences of respiratory infections in children Year: 2014 Association of allergy with chronic sinusitis in children Source: International Congress 2014 – Clinical allergy Year: 2014 Clinical phenotypes in non-cystic fibrosis bronchiectasis (NCFBE) Source: International Congress 2014 – Interventions and other therapeutic approaches in respiratory infections Year: 2014 Pulmonary manifestation of X-linked agammaglobulinemia Source: International Congress 2014 – Respiratory infections in children Year: 2014 Fungal sensitization in patients with moderate and severe asthma Source: International Congress 2014 – Clinical allergy Year: 2014 Immunoproteasome expression in pulmonary fibrosis Source: Annual Congress 2013 –Cell signalling and inflammation: what's new in 2013? Year: 2013 Clinical picture analysis of idiopathic pulmonary fibrosis (IPF) and lung cancer (LC) concomitance in the population of patients hospitalized in Ist Clinic of Lung Diseases Institute for Tuberculosis and Lung Diseases in Warsaw, Poland in the years 1994-2009 Source: Annual Congress 2011 - What is new in the approach to pulmonary fibrosis? Year: 2011 Importance of immunostimulation for community acquired pneumonia management Source: International Congress 2014 – Biomarkers of asthma and clinical immunology Year: 2014 Risk of asthma in heterozygous carriers for cystic fibrosis: A meta-analysis Source: International Congress 2016 – Cystic fibrosis: various aspects Year: 2016 Outcomes of immunotherapy of patients with COPD Source: International Congress 2014 – Intervening in allergic asthma Year: 2014 Cohort study of patients with asthma and immunodeficiency Source: International Congress 2014 – Asthma: clinical problems Year: 2014 LATE-BREAKING ABSTRACT: A phase 2 study of benralizumab on exacerbations, lung function, and asthma control in adults with uncontrolled eosinophilic asthma Source: International Congress 2014 – The future has started: emerging potentials for personalised asthma treatment Year: 2014 Steroid sparing effect of anti-IgE antibody in allergic bronchopulmonary aspergillosis (ABPA) complicating cystic fibrosis Source: Annual Congress 2013 –Cystic fibrosis: clinical problems, genetics and microbiology in children Year: 2013 Aspergillus skin hypersensitivity in patients of COPD Source: International Congress 2014 – Clinical allergy Year: 2014 Immunology indices in severe bronchial asthma with different levels of disease control in children Source: Annual Congress 2013 –Asthma Year: 2013